Skip to main content
SpringerLink
Log in

Sharad Gogate: Guidelines and Standards for Maternal Serum Screening for Down’s Syndrome, Neural Tube Defects, and Other Obstetric Problems

CBS Publishers & Distributors Pvt Ltd, New Delhi, ISBN: 978-81-239-2626-1

  • Book Review
  • Published:
The Journal of Obstetrics and Gynecology of India Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Milunsky A, Canick JA. Maternal serum screening for neural tube and other defects. In: Milunsly ED, editor. Genetic disorders and the fetus. Baltimore: John Hopkins University Press; 2004. p. 719–94.

    Google Scholar 

  2. Chaoui R, Benoit B, Mitkowska-Wozniak H, et al. Assessment of intracranial translucency (IT) in the detection of spina bifida at the 11-13-week scan. Ultrasound Obstet Gynecol. 2009;34(3):249–52.

    Article  CAS  PubMed  Google Scholar 

  3. Canick JA, Knight GJ. Low 2nd trimester maternal unconjugated serum estriol in pregnancies with T21. Br J Obstet Gynaecol. 1988;95:330.

    Article  CAS  PubMed  Google Scholar 

  4. Nicolaides KH. Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn. 2011;31(1):7–15.

    Article  PubMed  Google Scholar 

  5. Maiz N, Valencia C, Kagan KO, et al. Ductus venosus Doppler in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33:512–7.

    Article  CAS  PubMed  Google Scholar 

  6. Kagan KO, Valencia C, Livanos P, et al. Tricuspid regurgitation in screening for trisomies 21, 18 and 13 and Turner syndrome at 11 + 0 to 13 + 6 weeks of gestation. Ultrasound Obstet Gynecol. 2009;33:18–22.

    Article  CAS  PubMed  Google Scholar 

  7. Nicolaides KH, Wright D, Poon LC, et al. First trimester screening for trisomy 21 by biochemistry and maternal cell free DNA testing. USG Obstet Gynecol. 2013;42:41–50.

    CAS  Google Scholar 

  8. Chetty S, Norton ME. Uptake of non invasive prenatal testing in women following positive aneuploidy screening. Prenat Diagn. 2013;33:542–6.

    Article  PubMed  Google Scholar 

  9. Staboulidou I, Galindo A, Maiz N, et al. First-trimester uterine artery doppler and serum pregnancy-associated plasma protein-A in preeclampsia and chromosomal defects. Fetal Diagn Ther. 2009;25:336–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. B/39, Avinash Bldg, 1st Flr, Opp Bank of India, Amrut Nagar, Ghatkopar West, Mumbai, 86, India

    Pooja Vaziraani

Authors
  1. Pooja Vaziraani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pooja Vaziraani.

Ethics declarations

Conflict of interest

There is no conflict of interest.

Additional information

Dr. Pooja Vaziraani is a Consultant in Fetal Medicine in the Department of High Risk Obstetrics, Dr. L.H. Hiranandani Hospital, Mumbai.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vaziraani, P. Sharad Gogate: Guidelines and Standards for Maternal Serum Screening for Down’s Syndrome, Neural Tube Defects, and Other Obstetric Problems. J Obstet Gynecol India 66, 68–70 (2016). https://doi.org/10.1007/s13224-015-0809-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13224-015-0809-3

Search

Navigation